The antitumor activity of exogenous and endogenous canstatin on colorectal cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2713-2716

  Xing, Ya Nan ^a   Liang, Hong Wei ^a   Zhao, Li ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Canstatin; Cell cycle; Colorectal cancer; Mobility

Indexed keywords

EID: 84863295163     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-64.
2. He GA, Luo JX, Zhang TY, et al (2003). Cloning and expression of human canstatin and its purification and bioactivity. Wei Sheng Wu Xue Bao, 43, 607-12.
3. He GA, Luo JX, Zhang TY, et al (2003). Expression and purification of the N-domain of human canstatin and its bioactivity. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, 35, 483-7.
4. Kamphaus GD, Colorado PC, Panka DJ, et al (2000). Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem, 275, 1209-15.
5. Kerbel RS (1997). A cancer therapy resistant to resistance. Nature, 390, 335-6.
6. Lee JM, Hwang-Bo J, Sohn BH, et al (2007). Functional expression of recombinant canstatin in stably transformed Drosophila melanogaster S2 cells. Protein Expr Purif, 52, 258-64.
7. Li YY, Qian GS, Huang GJ, et al (2006). Enhancement of antiangiogenic effects of human canstatin with a hypoxiaregulated transgene vector in lung cancer model. Cancer J, 12, 136-46
8. Madri, JA (1997). Extracellular matrix modulation of vascular cell behaviour. Transplant Immunol, 5, 179-83.
9. Maeshima Y, Colorado PC, Torre A, et al (2000). Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem, 275, 21340-8.
10. Magnon C, Galaup A, Mullan B, et al (2005). Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with αvβ3 and αvβ5 integrins. Cancer Res, 65, 4353-61.
11. Malin S, Yuki H, Hikaru S, et al (2005). Function of endogenous inhibitors of angiogenesis as endothelium specific tumor suppressors. PNAS, 102, 2934-9.
12. Miyake H, Hara I, Hara S, et al (2000). Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model. Urology, 56, 332-6.
13. Narazaki M, Tosato G (2006). Canstatin: an inhibitor of angio-genesis and tumor growth revisited. Cancer J, 12, 110-2.
14. O'Connell JB, Maggard MA, Ko CY (2004). Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst, 6, 1420-5.
15. Okumura K, Nakase M, Nakamura S, et al (2007). Bax gene therapy for human osteosarcoma using cationic liposomes in vivo. Oncol Rep, 17, 769-73.
16. Panka DJ, Mier JW (2003). Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells. J Biol Chem, 278, 37632-6.
17. Potter JD (1999). Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916-32.
18. Prockop DJ, Kivirikko KI (1995).Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem, 64, 403-34.
19. Timpl R (1996). Macromolecular organization of basement membranes. Curr Opin Cell Biol, 8, 618-24.
20. Tuve S, Racek T, Niemetz A, et al (2006). Adenovirus-mediated TA-p73beta gene transfer increases chemosensitivity of human malignant melanomas. Apoptosis, 11, 235-43.
21. Vogelstein B, Kinzler KW (1993). The multistep nature of cancer. Trends Genet, 9, 138-41.
22. Wang WB, Zhou YL, Heng DF, et al (2008). Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice. Breast Cancer Res Treat, 110, 283-95.
23. Weitz J, Koch M, Debus J, et al (2005). Colorectal cancer. Lancet, 365, 153-65.